• Like
LOE and SOR criteria
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

LOE and SOR criteria


PPT presentation for Duke EBM conference

PPT presentation for Duke EBM conference

Published in Health & Medicine
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads


Total Views
On SlideShare
From Embeds
Number of Embeds



Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

    No notes for slide


  • 1. Level of evidence, strength of recommendations, and patient-centered care
  • 2. Describe the concept of “levels of evidence (LOE)” and explain which research study designs lead to certain levels of evidence. 2. Define the term “strength of recommendation taxonomies (SORT)” and give examples of two organizations’ SORT criteria. 3. Evaluate clinical practice guidelines by using LOE and SORT, and summarize the evidencebased applicability of these guidelines. 1.
  • 3.  While covering the ER, an 18 year-old male presents with acute shortness of breath. His symptoms had present over the past 8 hours, but acutely worsened 30 minutes ago.  On arrival, he is tachypneic, using accessory muscles, and only able to speak in short sentences. His RR is 36, with supra-sternal retractions. Pulse Ox is 94%, and his peak flow is <40% predicted.
  • 4.  The patient is placed on supplemental O2, and he is given 3 combined albuterol/ipratropium nebulizer treatments. Despite this, he does not improve significantly.
  • 5.  What are your next treatment options?  How will you know if what you *think* is the next step will be an effective next step?  How can we quickly and efficiently assess the quality of evidence?
  • 6.  Level of evidence (LOE)  Strength of recommendation (SOR)
  • 7.  Provides a quick overview  How reliable is the study’s findings?  How much bias is likely?  How “good” is this study?
  • 8.  Study design affects likely LOE: more robust studies usually lead to better LOE  Review of study design:      Randomized-controlled trials Cohort studies Case-control studies Case series or case reports Also: reviews and syntheses of prior studies
  • 9.  Oxford Centre for Evidence-Based Medicine  Updated 2011  Divides criteria by the question being asked  A “gold standard”?  Level 1-5  Level 1 is the highest/least-biased/”best” evidence, usually from RCTs, systematic reviews, etc.  Level 5 evidence is mechanism-based reasoning.
  • 10.  Assesses the usefulness of clinical recommendations  Usually seen in the context of point-of-care tools, evidence-based summaries, etc.  Provides a patient-centered review of clinical evidence  Incorporates patient-centered outcomes and level of evidence
  • 11.  Disease-oriented outcomes: “These outcomes include intermediate, histopathologic, physiologic, or surrogate results (ie, blood sugar, blood pressure, flow rate, coronary plaque thickness) that may or may not reflect improvements in patient outcomes”  Patient-centered outcomes: “These are outcomes that matter to patients and help them live longer or better lives, including reduced morbidity, reduced mortality, symptom improvement, improved quality of life, or lower cost”
  • 12.  Disease-oriented outcomes: Measurements that scientifically or physiologically “make sense” in terms of disease management (BP, A1c, FEV1, etc.); surrogate outcomes.  Patient-centered outcomes: Events that actually make a tangible difference in patients’ lives (hospitalizations, death, etc.)
  • 13.  Studies that show apparently beneficial changes in surrogate outcomes may not improve (or may worsen) patient outcomes  Surrogate outcomes are easier to study, and those studies are more common  SOR taxonomies allow a rapid overview of patient-oriented recommendations
  • 14.  Study designs also tend to predispose to certain SOR…if those studies used patientoriented outcomes, better studies lead to better SOR  Different organizations use different approaches to define SOR  Are you familiar with any particular SOR taxonomies?
  • 15.  USPSTF  A, B, C, D, I  AAFP  A, B, C  AAP:  strong recommendation, recommendation, option, no recommendation  ACP = USPSTF  Cochrane/BMJ GRADE  strong, weak
  • 16.  How would you determine the next steps in treating our patient?  Search for guidelines that answer the clinical question (5 mins)  Report back re: what you found and the quality of the evidence
  • 17.  What is the LOE or SOR associated with the guidelines you found?  How confident are you in these guidelines?
  • 18.  LOE and SORT will NOT  Provide definitive judgment  Provide definitive treatment recommendations unless ▪ the study population represents your population ▪ the outcome is patient-centered and clinically-relevant, treatment is appropriate ▪ no other treatment is superior
  • 19.  LOE and SOR are interrelated and complementary  LOE focuses on individual studies, SOR on the aggregate  LOE and SOR help guide clinical decisionmaking, but do not dictate it
  • 20.  “What does this mean?”  LOE  How good is this evidence?  How much can I trust it?  “What do I do with it?”  SOR  How can I best use this evidence?  What does this evidence mean to me and my patients?